Literature DB >> 15711803

Somatostatin for intractable postoperative chylothorax in a premature infant.

S A Clarke1, K Lakhoo, W Sherwood.   

Abstract

A premature infant of 31 weeks' gestation underwent repair of an oesophageal atresia, distal tracheo-oesophageal fistula and anal stenosis. A lymphatic leak was noted at the time of surgery. Chylous drainage persisted and an intravenous infusion of somatostatin was begun. The volume of chyle drained fell dramatically within the first 24 h and was negligible by the 5th day of treatment. No reaccumulation of the chylothorax was seen after the cessation of somatostatin. To our knowledge this is the youngest reported child in whom somatostatin has been used successfully in treating a postoperative chylothorax.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15711803     DOI: 10.1007/s00383-004-1361-x

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  15 in total

1.  Successful use of somatostatin in a case of neonatal chylothorax.

Authors:  Macy Au; Thomas R Weber; Robert E Fleming
Journal:  J Pediatr Surg       Date:  2003-07       Impact factor: 2.545

2.  Treatment of a persistent postoperative chylothorax with somatostatin.

Authors:  P C Rimensberger; B Müller-Schenker; A Kalangos; M Beghetti
Journal:  Ann Thorac Surg       Date:  1998-07       Impact factor: 4.330

3.  Octreotide as a therapeutic option for management of chylothorax.

Authors:  Sulaiman A Al-Zubairy; Abdulrazaq S Al-Jazairi
Journal:  Ann Pharmacother       Date:  2003-05       Impact factor: 3.154

4.  Somatostatin: a new therapeutic option for the treatment of chylothorax.

Authors:  V Buettiker; M I Hug; R Burger; O Baenziger
Journal:  Intensive Care Med       Date:  2001-06       Impact factor: 17.440

5.  Treatment of persistent chylothorax after Norwood procedure with somatostatin.

Authors:  Timothy W Pettitt; Joseph Caspi; Anne Borne
Journal:  Ann Thorac Surg       Date:  2002-03       Impact factor: 4.330

6.  Octreotide for treatment of postoperative chylothorax.

Authors:  Y Cheung ; M P Leung; M Yip
Journal:  J Pediatr       Date:  2001-07       Impact factor: 4.406

7.  Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia.

Authors:  Anju Goyal; Nicola P Smith; Edwin C Jesudason; Steve Kerr; Paul D Losty
Journal:  J Pediatr Surg       Date:  2003-08       Impact factor: 2.545

8.  Management of pediatric postoperative chylothorax.

Authors:  S J Bond; P C Guzzetta; M L Snyder; J G Randolph
Journal:  Ann Thorac Surg       Date:  1993-09       Impact factor: 4.330

9.  Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.

Authors:  I Cirera; F Feu; A Luca; J C García-Pagán; M Fernández; A Escorsell; J Bosch; J Rodés
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

10.  Current concepts in the management of postoperative chylothorax.

Authors:  M K Ferguson; A G Little; D B Skinner
Journal:  Ann Thorac Surg       Date:  1985-12       Impact factor: 4.330

View more
  4 in total

1.  Successful doxycycline treatment of lymphatic fistulas: report of five cases and review of the literature.

Authors:  Thilo Hackert; Jens Werner; Martin Loos; Markus W Büchler; Jürgen Weitz
Journal:  Langenbecks Arch Surg       Date:  2006-05-09       Impact factor: 3.445

Review 2.  Surgical chylothorax in neonates: management and outcomes.

Authors:  Karina Miura Costa; Amulya Kumar Saxena
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

3.  Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review.

Authors:  João Moreira-Pinto; Paula Rocha; Angélica Osório; Berta Bonet; Fátima Carvalho; Carlos Duarte; Luísa Oliveira
Journal:  Pediatr Surg Int       Date:  2010-09-07       Impact factor: 1.827

Review 4.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.